In this issue:
Location, location, location
Oxford pours oil on troubled SEAS
Alpha for omega-3 but not for statins in heart failure
More bad news for fatty hearts
Telmisartan fails to TRANSCEND ACE inhibitors
Slow is BEAUTIFUL but cosmetic effects of ivabradine were marginal
The wages of CIN may be death or worsening renal failure but are not
ameliorated by base infusion
Degrading DES polymer is nevertheless non-inferior
Quality of life not shocking for most with an ICD
Things to do while waiting for the surgeon
Please login below to download this issue (PDF)